Global Healthcare Analytical Testing Services Market 2017-2021
About Healthcare Analytical Testing Services
Analytical testing in healthcare is critical as it ensures that the products are of high-quality and free from any impurities, which could contaminate the products during manufacturing or the early stages of product development. The term can also be referred to as materials testing and is collectively given to the various techniques used to identify the chemical composition or characteristics of a particular sample.
Technavio’s analysts forecast the global healthcare analytical testing services market to grow at a CAGR of 9.87% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global healthcare analytical testing services market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Healthcare Analytical Testing Services Market 2017-2021
Technavio recognizes the following companies as the key players in the global healthcare analytical testing services market: Charles River Laboratories, Eurofins Scientific, SGS, and Thermo Fisher Scientific.
Other Prominent Vendors in the market are: Anacura, Bioreliance Corporation, Envigo, Exova, Intertek Group, Medistri, Pace Analytical Services, Pharmaceutical Product Development, Source Bioscience, and WuXi AppTec.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is increasing outsourcing of analytical testing services. As the pharmaceutical and biotechnology companies seek to reduce the cost and time of the manufacturing process, a growing trend of outsourcing the analytical testing services to CRO has developed. This outsourcing helps the companies to keep control of the testing procedure, retain proprietary knowledge, and free up resources for R&D.”
According to the report, one driver in the market is growing acceptance of QbD approach in research and manufacturing. Quality has been of utmost importance to pharmaceutical manufacturers. Drug developers have traditionally used late-stage quality testing to ensure safe and tested products reach the patients. This approach has been successful in the past, but there is another growing phenomenon in the industry, which is rapidly changing the drug manufacturing paradigm. QbD approaches are emerging rapidly in the market and are currently compelling pharmaceutical companies to shift from traditional manufacturing practices to systematic, data-driven strategies for delivering quality outcomes.
Further, the report states that one challenge in the market is changing formulations in product design. Over the years, efficient analytical testing methods have been developed for chemical formulations, which are commonly used. However, at present, numerous new formulations are being discovered and developed into medicines through extensive research. These new classes of molecules or chemical conjugates are difficult to analyze. Patient-specific cancer vaccines require a different conceptual approach, in which some (routine) test methods should test for non-patient-specific manufacturing (batch-to-batch) consistency, while the others should test for patient-specific critical quality attributes.
Charles River Laboratories, Eurofins Scientific, SGS, Thermo Fisher Scientific, Anacura, Bioreliance Corporation, Envigo, Exova, Intertek Group, Medistri, Pace Analytical Services, Pharmaceutical Product Development, Source Bioscience, and WuXi AppTec.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook